NEUROSTASIN
Live / Allowed — Approved for publication (as of 09 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Jul 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 50008319
- Mark type
- Stylized text
- Filed
- 22 Jul 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations in the form of nanoliposomes for the treatment of Alzheimers diseases and other proteinopathies; Drug delivery agents in the form of nanoliposomes that targets neural tissues that facilitate the delivery of pharmaceutical preparations
Owner
- Biom Pharmaceutical Corporation, Sarasota, FL, US
Prosecution history
- 09 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Aug 2026 — EXAMINER'S AMENDMENT ENTERED
- 11 Aug 2026 — EXAMINERS AMENDMENT E-MAILED
- 11 Aug 2026 — EXAMINERS AMENDMENT -WRITTEN
- 10 Aug 2026 — ASSIGNED TO EXAMINER
- 26 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Jul 2026 — NEW APPLICATION ENTERED
- 22 Jul 2026 — APPLICATION FILING RECEIPT MAILED